Ann B. Barshinger Cancer Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17604.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Ann B. Barshinger Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Sponsors: Hoffmann-La Roche.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ann B. Barshinger Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ann B. Barshinger Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Ann B. Barshinger Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.